Key Ingredients:
“Dual Glowy Lip Brush 933” has been added to your cart. View cart
Niacin Acvita White Patch 54pcs
$9.24
excl. shipping
Categories: Acne, Health & Wellness
Brand:CURESYS
Our Favorite Features
Why Choose Gwenchanda?
- Fast Processing – 2.5 days on average
- Quick Shipping – 2.8 days on average
- 99.7% Fulfillment Rate – Almost always in stock
- 100% Authentic – Straight from Korea
- Great Prices – Over 50% of products on sale
Skin care | Dullness |
---|
Made in | South Korea |
---|
Brand
CURESYS
CURESYS – Professional Skin Care for Daily Use!
CURESYS, derived from “cure” and “system,” is a Korean skincare brand that delivers professional-grade solutions for daily skincare routines. Developed with the UK-based Skin Damage Revive Lab, CURESYS formulates its products with dermatology-backed ingredients to effectively address skin concerns. Every product undergoes strict quality control under CGMP standards, ensuring safety and efficacy. Bestsellers like the Dark Spot AC Patch and Trouble Clear Needle Patch provide targeted care for blemishes and troubled skin. Made entirely in Korea, CURESYS blends innovation with proven science for healthier skin. Explore CURESYS skincare now at Gwenchanda!
Only logged in customers who have purchased this product may leave a review.
Related products
-
Pefect Foot Peeling Kit (Foot Softener Spray + Foot File)
Foot care$14.25Original price was: $14.25.$12.09Current price is: $12.09. -
Blemish Spot Care Patch 72P Set (+18P)
Acne$9.34Original price was: $9.34.$6.16Current price is: $6.16. -
Madeca ACQ Spot Patch Pro 9 Counts
Acne$9.73Original price was: $9.73.$8.75Current price is: $8.75.
Recently viewed products
-
Revital Elixir Shampoo 400ml
Hair wash$51.10Original price was: $51.10.$45.99Current price is: $45.99. -
Colla-Juvenation Lift 4 Overday + Night Treatment Balm 50ml
Cream$33.41Original price was: $33.41.$26.73Current price is: $26.73. -
Under-Eye Volume Pencil 1.1g
Eyeliner$15.72Original price was: $15.72.$13.37Current price is: $13.37.
Reviews
There are no reviews yet.